Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human MOS Protein, N-His

Catalog #:   YHB87001 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P00540
Protein length: Ser54-Gly346
Overview

Catalog No.

YHB87001

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser54-Gly346

Predicted molecular weight

34.29 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P00540

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Proto-oncogene serine/threonine-protein kinase mos, 2.7.11.1, Oocyte maturation factor mos, Proto-oncogene c-Mos, MOS

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human MOS protein
References

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails., PMID:40495210

A Fluorescent Aptamer Sensor for Detecting Golgi Protein 73 Based on Magnetic Ferroferric Oxide@Boron, Nitrogen-Doped Graphene Quantum Dots., PMID:40485103

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis., PMID:40481442

A Biodegradable 2D Metallic MoS2 Genesheet for Synergistic NIR-II Photothermal Immunotherapy., PMID:40457643

Exploring the Impact of Selected Functional Feed Additives on Growth Performance, Nutrient Utilization, Enzyme Activities and Immune Gene Expression of Striped Murrel (Channa striata) Juveniles., PMID:40439863

Degradable Starch Microsphere Transarterial Chemoembolization as Salvage Therapy in Patients with Uveal Melanoma Liver Metastases., PMID:40436267

Disrupted MOS signaling alters meiotic cell cycle regulation and the egg transcriptome., PMID:40424049

Ultrasensitive Analysis of BRCA-1 Based on Gold Nanoparticles and Molybdenum Disulfide Electrochemical Immunosensor with Enhanced Signal Amplification., PMID:40422069

Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration., PMID:40413463

A Supramolecular Material for Controlling Kiwifruit Bacterial Canker., PMID:40411415

Molecular insights into RNA recognition by the ZAR1 C-terminal domain., PMID:40388637

Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial., PMID:40386729

Two-Dimensional MoS2 Field-Effect Biosensor for Highly Sensitive Detection of Cardiac Troponin I., PMID:40377210

Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations., PMID:40373457

A novel sperm-derived seminal fluid protein in Caenorhabditis nematodes., PMID:40359166

Real world study on efficacy and safety of surufatinib in advanced solid tumors evaluation., PMID:40348748

[Moslosooflavone ameliorates dextran sulfate sodium-induced colitis in mice by suppressing intestinal epithelium apoptosis via inhibiting the PI3K/AKT signaling pathway]., PMID:40294932

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study., PMID:40293533

Sensitive amperometric immunosensor for pathogen antigen based on MoS2@AuNPs assembling dual-peptide as bioprobes with significant dual signal amplification., PMID:40274335

Self-healing hydrogel based on polyvinyl alcohol/dextran with hyperglycemia-triggered cascade enzyme catalytic activity promotes diabetic wound healing., PMID:40253862

Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin., PMID:40252634

In vitro sulfuration of Rhodobacter capsulatus formate dehydrogenase., PMID:40246024

Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer., PMID:40240996

Impact of age, HIV1, sickle-cell genotypes, and interferon-gamma gene upstream variants on malaria disease outcomes in a longitudinal pediatric cohort., PMID:40234522

A pilot study of morphological features of the eyelid margin with conjunctival goblet cells and MUC5AC in tear film of dry eye., PMID:40220145

Somatostatin and Mannooligosaccharide Modified Selenium Nanoparticles with Dual-Targeting for Ulcerative Colitis Treatment., PMID:40214514

Orientation dependence of current blockade in single amino acid translocation through a graphene nanopore., PMID:40213903

Loading of hyaluronic acid-conjugated MoS2 nanosheets with rhodamine B for sensing hyaluronidase activity in human urine and live cells., PMID:40209530

The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials., PMID:40207218

Prognostic significance of ALK high expression in SCLC: a 9-year cohort analysis., PMID:40201354

Combination of antiangiogenic and systemic therapy in advanced non-small cell lung cancer: before and after progression to leptomeningeal metastasis., PMID:40195350

Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus)., PMID:40174460

Emerging SERS and TERS MoS2 platforms for the characterization of plasma-derived extracellular vesicles., PMID:40163166

Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancer., PMID:40162507

First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis., PMID:40136352

Mechanistic insights into cyclodextrins as substrates and inhibitors of GH57 family amylopullulanase from Aquifex aeolicus., PMID:40120836

A novel optical fiber immunosensor for detection of heart failure marker ST2 based on MoS2-modified D-shaped ExTFG., PMID:40120516

PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer., PMID:40116923

Correlative analysis of immune-related thyroid dysfunction and prognosis in patients with advanced esophageal squamous cell carcinoma., PMID:40112209

α-Lipoate Functionalized Triblock Copolymers Enable In Situ Exfoliation of Molybdenum(IV) Disulfide into Nanosheets in Base Oils for Enhanced Friction and Wear Reduction., PMID:40108789

The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort study., PMID:40099013

Association of anti-PD-(L)1 treatment duration to efficacy in advanced solid tumors: a single center retrospective study., PMID:40091413

A genetically encoded fluorescent sensor enables sensitive and specific detection of IDH mutant associated oncometabolite D-2-hydroxyglutarate., PMID:40087637

Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma., PMID:40078069

Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma., PMID:40057923

pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy., PMID:40056560

Efficacy and safety analysis of atezolizumab continuation beyond progression in extensive-stage small cell lung cancer., PMID:40038111

Efficacy and safety of sintilimab combined with trastuzumab and chemotherapy in HER2-positive advanced gastric or gastroesophageal junction cancer., PMID:40028325

Inequalities in Drug Access for Advanced Melanoma: The Prognostic Impact Resulting From the Approval Delay of the Combined Ipilimumab/Nivolumab Treatment in Portugal., PMID:40027067

A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus Venetoclax., PMID:40023757

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human MOS Protein, N-His [YHB87001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only